Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Qiang Wang; Yuemei Xi; Binyang Chen; Hairong Zhao; Wei Yu; De Xie; Weidong Liu; Furong He; Chenxi Xu; Jidong Cheng

doi:10.3389/fphar.2022.1022539

Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Front Pharmacol. 2022 Nov 1:13:1022539. doi: 10.3389/fphar.2022.1022539. eCollection 2022.

Authors

Qiang Wang^{1

2}, Yuemei Xi^{1

2}, Binyang Chen^{1

2}, Hairong Zhao^{1

2}, Wei Yu^{1

2}, De Xie^{1

2}, Weidong Liu^{1

2}, Furong He^{1

2}, Chenxi Xu^{1

2}, Jidong Cheng^{1

2}

Affiliations

¹ Department of Internal Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
² Xiamen Key Laboratory of Translational Medicine for Nucleic Acid Metabolism and Regulation, Xiamen, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.907133.].

Keywords: apoptosis; cisplatin-induced nephrotoxicity; fatty acid oxidation; inflammation; rage.

Publication types

Published Erratum